Novo Plans to Seek U.S. Approval for Its High-Dose Obesity Shot

Novo Nordisk is boosting its weight-loss efforts! They'll seek US approval for a high-dose Wegovy to match Lilly's Zepbound and are developing a pill version. They're also testing a new compound, cagrilintide, to regain market leadership.